Sign In
Last checked at 
21 Dec 2020 07:00
PDMR DEALING NOTIFICATION
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||
a) | Name | Robert Langer | ||||||||
2 | Reason for the notification | |||||||||
a) | Position/status | Director | ||||||||
b) | Initial notification/Amendment | Initial notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | PureTech Health plc | ||||||||
b) | LEI | 213800LVPDNO2Z9T9I39 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument Identification code |
ISIN GB00BY2Z0H74 | ||||||||
b) | Nature of the transaction | A transfer of Ordinary Shares for nil consideration from Robert Langer to the Langer Family 2020 Trust. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information
|
| ||||||||
e) | Date of the transaction | 17 December 2020 | ||||||||
f) | Place of the transaction | Outside of a trading venue | ||||||||
Follow the stocks
